{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:45:55Z","timestamp":1793641555489,"version":"4.5.1"},"reference-count":76,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,2,12]],"date-time":"2007-02-12T00:00:00Z","timestamp":1171238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alcoholism Clin &amp;amp; Exp Res"],"published-print":{"date-parts":[[2007,4]]},"abstract":"<jats:p><jats:bold>Background:<\/jats:bold>Repeated exposures to forced ethanol diets (EDs) or restraint stress sensitize anxiety\u2010like behavior during a future ethanol withdrawal. The present investigation assessed whether pretreatment of rats with agents targeting receptor systems thought to be important in treating relapse in alcoholic patients would prevent sensitization of anxiety\u2010like behavior.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold>Groups of rats were exposed to either (1) three 5\u2010day cycles of ED with 2 days of withdrawal between cycles, (2) continuous ED, or (3) 5 days of ED in a single cycle preceded by 2 episodes of restraint stress 6 days apart. Drugs [baclofen, acamprosate, naloxone, lamotrigine, ifenprodil, dizocilpine (MK\u2010801), CGS19755, diazepam, flumazenil, or 6\u2010methyl\u20102\u2010(phenylethynyl)pyridine] were given prophylactically during the first and second withdrawal periods only or, in separate baclofen experiments, acutely during the third withdrawal or during withdrawal from continuous ED. Baclofen administration preceded each stress session in the stress\u2010withdrawal protocols. Anxiety\u2010like behavior was assessed in the social interaction (SI) test 5 hours after the ethanol was removed or after 3 days of abstinence.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold>Baclofen (1.25, 2.5, and 5 mg\/kg), flumazenil (5 mg\/kg), and diazepam (1 mg\/kg) blocked the reduction in SI induced by ethanol withdrawal. Among the drugs that alter glutamate function, only acamprosate (300 mg\/kg) was effective. In the stress protocols, baclofen (5 mg\/kg) given before each of the 2 restraint stress sessions before ethanol exposure or before stress during abstinence also attenuated SI deficits.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold>These findings suggest that GABA<jats:sub>B<\/jats:sub>and GABA<jats:sub>A<\/jats:sub>, but not glutamate or opioid mechanisms, are involved in adaptive changes associated with anxiety\u2010like behavior induced by these repeated ethanol\u2010withdrawal and stress\u2010withdrawal paradigms. The lack of action of agents attenuating different aspects of glutamate function suggests that acamprosate's action is related to some other, as yet undetermined, mechanism.<\/jats:p>","DOI":"10.1111\/j.1530-0277.2007.00342.x","type":"journal-article","created":{"date-parts":[[2007,2,13]],"date-time":"2007-02-13T01:35:47Z","timestamp":1171330547000},"page":"582-595","source":"Crossref","is-referenced-by-count":57,"title":["Baclofen Blocks Expression and Sensitization of Anxiety\u2010Like Behavior in an Animal Model of Repeated Stress and Ethanol Withdrawal"],"prefix":"10.1111","volume":"31","author":[{"given":"Darin J.","family":"Knapp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Overstreet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Breese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,2,12]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2000.tb04555.x"},{"key":"e_1_2_6_3_1","first-page":"504","article-title":"Baclofen efficacy in reducing alcohol craving and intake","volume":"37","author":"Addolorato G","year":"2002","journal-title":"a preliminary double-blind, randomized controlled study"},{"key":"e_1_2_6_4_1","first-page":"276.e13","article-title":"Baclofen in the treatment of alcohol withdrawal syndrome","volume":"119","author":"Addolorato G","year":"2006","journal-title":"a comparative study vs diazepam"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2000.00295.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(97)00505-4"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2003.tb04414.x"},{"issue":"1","key":"e_1_2_6_8_1","first-page":"S53","article-title":"Current pharmacotherapies of alcoholism","volume":"12","author":"Anton RF","year":"2003","journal-title":"a U.S. perspective"},{"key":"e_1_2_6_9_1","first-page":"10679","article-title":"Ethanol potentiation of GABAergic synaptic transmission may be self\u2010limiting","volume":"24","author":"Ariwodola OJ","year":"2004","journal-title":"role of presynaptic GABAB receptors"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007672008297"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.1.1"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.1998.tb03636.x"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(01)01485-0"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-0301-3"},{"key":"e_1_2_6_15_1","first-page":"2","article-title":"Gamma\u2010aminobutyric acid(B) receptors","volume":"292","author":"Bowery NG","year":"2000","journal-title":"first of the functional metabotropic heterodimers"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(00)00286-0"},{"key":"e_1_2_6_17_1","first-page":"185","article-title":"Stress enhancement of craving during sobriety","volume":"29","author":"Breese GR","year":"2005","journal-title":"a risk for relapse"},{"key":"e_1_2_6_18_1","first-page":"470","article-title":"Stress sensitization of ethanol withdrawal\u2010induced reduction in social interaction","volume":"29","author":"Breese GR","year":"2004","journal-title":"inhibition by CRF1 and benzodiazepine receptor antagonists and a 5-HT1A receptor agonist"},{"key":"e_1_2_6_19_1","first-page":"1662","article-title":"Prior multiple ethanol withdrawals enhance stress\u2010induced anxiety\u2010like behavior","volume":"30","author":"Breese GR","year":"2005","journal-title":"inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050825"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300540"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(88)90523-9"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050937"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(03)03163-9"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(98)00253-6"},{"key":"e_1_2_6_26_1","first-page":"58","article-title":"Ability of baclofen in reducing alcohol intake and withdrawal severity","volume":"24","author":"Colombo G","year":"2000","journal-title":"I\u2014Preclinical evidence"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(02)00333-2"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100869"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-200102000-00009"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1C465"},{"key":"e_1_2_6_31_1","first-page":"785","article-title":"Kindling of withdrawal","volume":"26","author":"Duka T","year":"2002","journal-title":"a study of craving and anxiety after multiple detoxifications in alcoholic inpatients"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-001-0519-5"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(03)01273-1"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(91)90202-M"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(92)90011-3"},{"key":"e_1_2_6_36_1","first-page":"1517","article-title":"Baclofen for alcohol dependence","volume":"28","author":"Flannery BA","year":"2004","journal-title":"a preliminary open-label study"},{"key":"e_1_2_6_37_1","first-page":"1318","article-title":"Pharmacological treatment of alcohol dependence","volume":"281","author":"Garbutt JC","year":"1999","journal-title":"a review of the evidence"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(99)00082-9"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1987.tb11244.x"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000093601.33119.E3"},{"key":"e_1_2_6_41_1","first-page":"858","article-title":"Modulation of A10 dopamine neurons by gamma\u2010aminobutyric acid agonists","volume":"253","author":"Kalivas PW","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_42_1","first-page":"481","article-title":"Induction of Fos\u2010like proteins and ultrasonic vocalizations during ethanol withdrawal","volume":"22","author":"Knapp DJ","year":"1998","journal-title":"further evidence for withdrawal-induced anxiety"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ALC.0000158840.07475.97"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.alcohol.2003.08.007"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011127"},{"key":"e_1_2_6_46_1","first-page":"403","article-title":"Baclofen as a cocaine anti\u2010craving medication","volume":"18","author":"Ling W","year":"1998","journal-title":"a preliminary clinical study"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2003.tb00492.x"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-6273(00)80381-5"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0741-8329(00)00114-2"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2002.tb02445.x"},{"key":"e_1_2_6_51_1","first-page":"394","article-title":"Multiple withdrawals from chronic ethanol \u201ckindles\u201d inferior collicular seizure activity","volume":"14","author":"McCown TJ","year":"1990","journal-title":"evidence for kindling of seizures associated with alcoholism"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/syn.10166"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1994.tb19819.x"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1995.tb06002.x"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050303"},{"key":"e_1_2_6_56_1","first-page":"208","article-title":"Enhanced ultrasonic vocalization and Fos protein expression following ethanol withdrawal","volume":"152","author":"Moy SS","year":"2000","journal-title":"effects of flumazenil"},{"key":"e_1_2_6_57_1","unstructured":"National Research Council (1996) Guide for the Care and Use of Laboratory Animals.http:\/\/www.nap.edu\/readingroom\/books\/labrats\/"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.104.003319"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(77)90834-4"},{"key":"e_1_2_6_60_1","first-page":"1761","article-title":"Suppression of alcohol intake by chronic naloxone treatment in P rats","volume":"23","author":"Overstreet DH","year":"1999","journal-title":"tolerance development and elevation of opiate receptor binding"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2002.tb02665.x"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2003.11.010"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-003-1425-y"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.171.1.73"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000562"},{"key":"e_1_2_6_66_1","first-page":"278","article-title":"Baclofen versus diazepam for the treatment of spasticity and long\u2010term follow\u2010up of baclofen therapy","volume":"4","author":"Roussan M","year":"1985","journal-title":"Pharmatherapeutica"},{"key":"e_1_2_6_67_1","first-page":"219","article-title":"Comorbid anxiety and affective disorder in alcohol\u2010dependent patients seeking treatment","volume":"36","author":"Schneider U","year":"2001","journal-title":"the first multicentre study in Germany"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100917"},{"key":"e_1_2_6_69_1","first-page":"215","article-title":"Novel structure having antagonist actions at both the glycine site of the N\u2010methyl\u2010D\u2010aspartate receptor and neuronal voltage\u2010sensitive sodium channels","volume":"292","author":"Snell LD","year":"2000","journal-title":"biochemical, electrophysiological, and behavioral characterization"},{"key":"e_1_2_6_70_1","first-page":"202","article-title":"Acamprosate and relapse prevention in the treatment of alcohol dependence","volume":"35","author":"Tempesta E","year":"2000","journal-title":"a placebo-controlled study"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1992.sp019167"},{"key":"e_1_2_6_72_1","first-page":"167","article-title":"Predictors of acamprosate efficacy","volume":"178","author":"Verheul R","year":"2005","journal-title":"results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2006.00259.x"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)90534-7"},{"key":"e_1_2_6_75_1","first-page":"1038","article-title":"Acamprosate","volume":"53","author":"Wilde MI","year":"1997","journal-title":"a review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification"},{"key":"e_1_2_6_76_1","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0022-3565(24)35044-X","article-title":"Baclofen inhibits heroin self\u2010administration behavior and mesolimbic dopamine release","volume":"290","author":"Xi ZX","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_6_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0028-3908(99)00126-4"}],"container-title":["Alcoholism: Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1530-0277.2007.00342.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1530-0277.2007.00342.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T19:21:41Z","timestamp":1736796101000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1530-0277.2007.00342.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,12]]},"references-count":76,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1111\/j.1530-0277.2007.00342.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1530-0277.2007.00342.x","archive":["Portico"],"relation":{},"ISSN":["0145-6008","1530-0277"],"issn-type":[{"value":"0145-6008","type":"print"},{"value":"1530-0277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2,12]]}}}